학술논문

HEK293 Cell Line as a Platform to Produce Recombinant Proteins and Viral Vectors
Document Type
article
Source
Frontiers in Bioengineering and Biotechnology, Vol 9 (2021)
Subject
HEK293
human embryonic kidney cell 293
biotechnology
viral vectors
viral vectored vaccines
biotherapeutics and biologics
Biotechnology
TP248.13-248.65
Language
English
ISSN
2296-4185
Abstract
Animal cell-based expression platforms enable the production of complex biomolecules such as recombinant proteins and viral vectors. Although most biotherapeutics are produced in animal cell lines, production in human cell lines is expanding. One important advantage of using human cell lines is the increased potential that the resulting biotherapeutics would carry more “human-like” post-translational modifications. Among the human cell lines, HEK293 is widely utilized due to its high transfectivity, rapid growth rate, and ability to grow in a serum-free, suspension culture. In this review, we discuss the use of HEK293 cells and its subtypes in the production of biotherapeutics. We also compare their usage against other commonly used host cell lines in each category of biotherapeutics and summarise the factors influencing the choice of host cell lines used.